Trial Profile
Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of the Effects of Titrated Oral Tolvaptan Tablets in Patients With Hyponatremia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jun 2015
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Hyponatraemia
- Focus Pharmacokinetics
- Acronyms SALT-1
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 05 Nov 2010 New trial record.